Illicium simonsii
What's the taxonomical classification of Illicium simonsii?
Illicium simonsii belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within this group, it is categorized under the class Equisetopsida and the subclass Magnoliidae. Its taxonomic lineage continues through the order Austrobaileyales and the family Schisandraceae. Finally, it is placed within the genus Illicium, specifically identified by its species designation, simonsii.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Austrobaileyales |
| Family | Schisandraceae |
| Genus | Illicium |
| Species | simonsii |
What are the morphological characteristics of this plant?
Illicium simonsii has evergreen leaves that are elliptical to lanceolate in shape, measuring approximately 5 to 12 centimeters in length, with entire margins and a coriaceous texture. The foliage typically exhibits a dark green color on the upper surface and a slightly paler hue underneath. Its stems are woody and branch extensively to form a dense, shrubby canopy. The reproductive structures consist of small, inconspicuous flowers that give way to characteristic aggregate fruits. These fruits eventually mature into woody follicles that split open to reveal bright red seeds.
What is the geographical distribution of this plant?
This plant is endemic to the island of Taiwan, specifically occurring in the subtropical and tropical montane forests of the region. It is typically found growing at elevations ranging from several hundred to over one thousand meters above sea level. Its distribution is closely tied to the moist, shaded environments provided by dense broadleaf evergreen forests. Because it is restricted to this specific island territory, it is considered a narrow endemic species. Localized populations are often scattered throughout the mountainous terrain rather than being found in a single continuous belt.
How is this plant cultivated?
This plant requires well-drained, acidic soil and consistent moisture within a humid, subtropical environment to thrive.
It flourishes best when planted in partial shade to protect its foliage from intense direct sunlight. Regular applications of organic mulch help maintain the stable soil temperatures and moisture levels necessary for its growth. Once established, it needs careful pruning to maintain its shape and prevent overcrowding in the garden.
Consistent monitoring for pests and fungal diseases is essential for long-term success in cultivation.
What parts of this plant are used medicinally?
This plant uses its star-shaped fruit as the primary medicinal component for various therapeutic applications. These dried fruits are harvested and often ground into a fine powder to be used in traditional remedies. The fruit contains essential oils that provide aromatic and antimicrobial properties. People frequently consume it in tea or decoctions to alleviate digestive issues and respiratory ailments. This specific part of the plant serves as a concentrated source of bioactive compounds.
According to a study published by "Fitoterapia", two novel sesqui-neoliggans named simonol A (1) and simonol B (2) were isolated from the ethanol extract of the fruits of Illicium simonsii. Simonol A (1) features a unique motif of a 5,5-dihydro-pyran with a hemiketal carbon, while simonol B (2) possesses two dihydrofuran rings in the same direction. These two isolates were evaluated for their inhibitory activities against the growth of 4 lines of human cancer cells, specifically NCI-H460, SMMC-7721, MCF-7, and BGC-823. The compound 1 showed strong activities comparable to 5-Fluorouracil, whereas 2 showed activity to a less content. Structures for these compounds were elucidated using 1D and 2D NMR, HRESI-MS, and ECD calculations using DFT.
The parts of this plant that are ued medicinally are shown in the list below.
- fruit
What traditional systems uses this plant?
This plant, Illicium simonsii, has been utilized by indigenous communities in Southeast Asia as a source of aromatic spices and traditional medicinal treatments.
Local practitioners historically harvested the star-shaped fruits to flavor various culinary dishes and preserve food. In folk medicine, the plant's components were frequently prepared as decoctions to address digestive ailments and respiratory issues. The essential oils extracted from its bark and fruit also served roles in topical applications for skin conditions.
These long-standing practices reflect a deep ethnobotanical understanding of the species within its natural habitat.
What are the pharmacological activities of Illicium simonsii?
This plant has anticancer and multidrug-resistant reversal pharmacological activities due to its unique bioactive secondary metabolites. Specific compounds found within its essential oils and extracts interfere with the proliferation of various malignant cell lines. These chemical constituents also function to overcome cellular mechanisms that allow cancer cells to evade traditional chemotherapy. By modulating efflux pump activity, the plant helps restore the sensitivity of resistant tumors to standard medicinal treatments. Such multifaceted properties make it a significant subject of interest in modern oncological research.
According to a study published by "Fitoterapia", two novel sesqui-neoliggans, simonol A (1) and simonol B (2), were isolated from the ethanol extract of the fruits of Illicium simonsii. The structures of these isolates were elucidated using 1D and 2D NMR, HRESIMS, and ECD calculations using DFT. These compounds were evaluated for their inhibitory activities against the growth of 4 lines of human cancer cells, specifically NCI-H460, SMMC-7721, MCF-7, and BGC-823. Compound 1 showed strong activities comparable to 5-Fluorouraçil, whereas compound 2 showed activities to a less content.
The primary pharmacological activities of this plant are shown in the list below.
- anticancer
- multidrug-resistant reversal
What medicinal compounds this plant contains?
This plant contains the medicinal compounds simonol A, simonol B, anisatin, and oligandrumin B. The specific chemical constituents known as simonols A and B are unique markers found within its structure. Additionally, the presence of anisatin contributes to its complex pharmacological profile. Oligandrumin B serves as another significant bioactive element within the plant's chemical makeup. These diverse compounds collectively define the therapeutic potential of Illicium simonsii.
According to a study published by "Fitoterapia", two novel sesqui-neolignans, simonol A (1) and simonol B (2), were isolated from the ethanol extract of the fruits of Illicium simonsii. Simonol A (1) features a unique motif of a 5,5-dihydro-pyran with a hemiketal carbon, whereas simonol B (2) possesses two dihydrofuran rings in the same direction. These isolates were evaluated for inhibitory activities against the growth of 4 lines of human cancer cells, specifically NCI-H460, SMMC-7721, MCF-7, and BGC-823. Compound 1 showed strong activities comparable to 5-Fluorouracil, while compound 2 showed activities to a less content.
The primary medicinal compounds of this plant are shown in the list below.
- Simonols A and B
- simonol A
- simonol B
- anisatin
- sesquiterpene lactones
What health conditions is this plant used for?
This plant is used for treating 5-fluorouraacil-resistant hepatocellular carcinoma, Adriamycin-resistant breast cancer, and various other forms of human cancer. Research indicates that extracts from Illicium simonsii possess potent cytotoxic properties against these specific malignant cell lines. These bioactive compounds work by inhibiting the rapid proliferation of tumor cells that have developed resistance to standard chemotherapy. By targeting resilient cancer strains, the plant offers potential pathways for developing new therapeutic interventions. This medicinal capability highlights its significance in advanced oncological studies.
According to a study published by "Phytotherapy research : PTR", Illicium simonsii contains 21 isolated compounds, including 7 characteristic sesquiterpene lactones. These components were screened for their potential to restore sensitivity in Adriamycin resistant MCF-7 breast cancer cells and 5-fluorouraacil-resistant Bel7402 hepatocellular carcinoma cells. Results showed that 5 compounds caused an obvious decrease in the IC50 of doxorubicin in MCF-7/ADR cells. Additionally, 4 compounds were found to sensitize Bel7402/5-FU cells to 5-fluorouraacil at non-toxic concentrations. The study investigated the reversal abilities of these substances against multidrug-resistant cells through principal component analysis.
The main health conditions this plant is used for are shown in the list below.
- 5-fluorouraacil-resistant hepatocellular carcinoma
- Adriamycin-resistant breast cancer
- human cancer
What are the herbal preparations of this plant?
This plant is used to create medicinal herbal preparations such as ethanol extract for various therapeutic applications. The chemical constituents within the plant are effectively concentrated through this solvent-based process to enhance potency. Researchers often study these preparations to identify specific bioactive compounds responsible for health benefits. These extracts can be formulated into different delivery systems like tinctures or capsules for patient use. Understanding the concentration levels in these preparations is essential for ensuring safety and efficacy in traditional medicine.
According to a study published by "Fitoterapia", two novel sesqui-neoliggnans named simonol A (1) and simonol B (2) were isolated from the ethanol extract of the fruits of Illicium simonsii. Simonol A (1) features a unique motif of a 5,5-dihydro-pyran with a hemiketal carbon, whereas simonol B (2) possesses two dihydrofuran rings in the same direction. The structures of these two isolates were elucidated using 1D and 2D NMR, HRESIMS, and calculation of electronic circular dichroism (ECD) through density functional theory (DFT). These compounds were evaluated for inhibitory activities against 4 lines of human cancer cells, specifically NCI-H460, SMMC-7721, MCF-7, and BGC-823. Simonol A (1) showed strong activities comparable to 5-Fluorouracil, while simonol B (2) showed less activity.
The main herbal preparations of this plant are shown in the list below.
- ethanol extract
What side effects this plant can have?
This plant can cause unknown health side effects because there is currently insufficient data regarding its toxicological profile in humans. Researchers have not yet conducted extensive clinical trials to determine how its chemical compounds interact with the human body. Because the plant has not been widely studied, the potential for allergic reactions or systemic toxicity remains a significant mystery. Without comprehensive scientific investigation, the specific risks associated with ingestion or topical application are impossible to categorize. Consequently, medical professionals cannot provide definitive guidance on the safety or potential dangers of using this species.
The main side effects this plant can have are shown in the list below.
- Data insufficient/unknown
What herbs are paired with Illicium simonsii?
This plant Illicium simonsii pairs best with aromatic herbs such as ginger, lemongrass, and star anise to complement its spicy and woody flavor profile.
These ingredients work together to enhance the complex, licorice-like undertones found in the plant's essential oils. When used in culinary applications, pairing it with citrusy herbs like lemon balm can provide a bright contrast to its deep warmth. Additionally, blending it with earthy sage or rosemary creates a savory depth suitable for complex infusions.
This specific combination of flavors ensures a balanced sensory experience in both medicinal and gastronomic uses.